Levy Adam D. sold ACRV
August 4, 2026 · Form 4 insider transaction
Levy Adam D. sold 1,142 shares of Acrivon Therapeutics, Inc. at $1.57 per share, a transaction worth $1.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,142
Price
$1.57
Total value
$1.8K
InsiderLevy Adam D.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after66,008
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.